Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares OutstandingShares Repurchased
Ratios

Genmab A (GNMSF) Shares Outstanding (2024 - 2025)

Historic Shares Outstanding for Genmab A (GNMSF) over the last 2 years, with Q3 2025 value amounting to $64206.3 billion.

  • Genmab A's Shares Outstanding fell 297.76% to $64206.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $64206.3 billion, marking a year-over-year decrease of 297.76%. This contributed to the annual value of $66187.2 billion for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Genmab A's Shares Outstanding stood at $64206.3 billion, which was down 297.76% from $64154.3 billion recorded in Q2 2025.
  • Genmab A's 5-year Shares Outstanding high stood at $66197.2 billion for Q1 2025, and its period low was $64154.3 billion during Q2 2025.